Author:
O’Brien Kylie,Blair Philip
Publisher
Springer International Publishing
Reference193 articles.
1. Australian Institute of Health and Welfare (AIHW). Dementia. 23 July, 2020. Available at: https://www.aihw.gov.au/reports/australias-health/dementia. Accessed 20 Nov 2020.
2. Prince M, Wimo A, Guerchet M, et al. The World Alzheimer Report 2015. The Global Impact of Dementia. An analysis of prevalence, incidence, costs and trends. London: Alzheimer’s Disease International; 2015.
3. Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer’s Disease: targeting the cholinergic system. Curr Neuropharmacol. 2016;14(1):101–15.
4. Russo EB. Cannabis therapeutics and the future of neurology. Front Integr Neurosci. 2018;12:51.
5. Hillen JB, Soulsby N, Alderman C, Caughey GE. Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review. Ther Adv Drug Saf. 2019;10:2042098619846993.